Torque3 is developing a neurorehabilitation solution that has shown in early testing to result in significantly better recovery outcomes.
A wealth of research over the last 30 years has strongly indicated that stroke recovery can be significantly improved through immersive stimulation and robotic assistance.
The Torque3 system leverages this research with an approach of uncompromising design and implementation combining a robotic chair and virtual reality.
In this episode, Founder/CEO David Ellzey shares some of the science behind Torque3 and insights into where they are headed.
Matt Patsky is CEO and Lead Portfolio Manager of the Trillium ESG Global Equity strategy and Portfolio Manager of the Trillium Sustainable Opportunities strategy....
TearSolutions' lead product, called Lacripep, delivers what no other approved or pipeline drug has been able to: rapid healing of the ocular surface and...
Dr. Krell is a fascinating general dentist with a combined business background. He is currently the Head of Marketing at Simplifeye, based in NYC,...
